임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

22건 표시

1상모집 중· Healthy
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
리드: 얀센(J&J)
상세 →NCT07669077
1상모집 중· Hematologic Neoplasms
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
리드: 얀센(J&J)
상세 →NCT07572006
1상모집 중· Schizophrenia
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
리드: 얀센(J&J)
상세 →NCT07615426
1상모집 중· Lymphoma, Non-Hodgkin
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
리드: 얀센(J&J)
상세 →NCT07308132
1상모집 중· Prostatic Neoplasms
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
리드: 얀센(J&J)
상세 →NCT07319871
1상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
협력: 얀센(J&J)
상세 →NCT07032714
1상모집 중· Acute Lymphoblastic Leukemia
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
리드: 얀센(J&J)
상세 →NCT07295951
1상모집 중· Advanced-stage Solid Tumors
A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
리드: 얀센(J&J)
상세 →NCT07223125
1상모집 중· Multiple Myeloma
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
협력: 얀센(J&J)
상세 →NCT06348108
1상모집 중· Colorectal Neoplasms
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
리드: 얀센(J&J)
상세 →NCT07107230
1상모집 중· Prostatic Neoplasms
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
리드: 얀센(J&J)
상세 →NCT07082920
1상모집 중· Leukemia, Myeloid, Acute
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
리드: 얀센(J&J)
상세 →NCT06651229
1상모집 중· Solid Tumors
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
협력: 얀센(J&J)
상세 →NCT06816992
1상모집 중· Multiple Myeloma
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
리드: 얀센(J&J)
상세 →NCT06768489
1상모집 중· Colorectal Neoplasms
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
리드: 얀센(J&J)
상세 →NCT06663319
1상모집 중· Malignant Primary Gliomas
5G-EMERALD: Amivantamab in Malignant Brain Tumours
협력: 얀센(J&J)
상세 →NCT06632236
1상모집 중· Human Immunodeficiency Virus
Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
협력: 얀센(J&J)
상세 →NCT06205056
1상모집 중· Neoplasms
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
리드: 얀센(J&J)
상세 →NCT06150157
1상모집 중· Neoplasms
A Study of JNJ-87890387 for Advanced Solid Tumors
리드: 얀센(J&J)
상세 →NCT06178614
1상모집 중· Prostatic Neoplasms
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
리드: 얀센(J&J)
상세 →NCT06095089
1상모집 중· Metastatic Castration-resistant Prostate Neoplasms
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
리드: 얀센(J&J)
상세 →NCT05818683
1상모집 중· Relapsed or Refractory Multiple Myeloma
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
리드: 얀센(J&J)
상세 →NCT05652335

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.